Skip to main content
Normal View

Vaccination Programme

Dáil Éireann Debate, Wednesday - 26 October 2011

Wednesday, 26 October 2011

Questions (145, 146)

Billy Kelleher

Question:

146 Deputy Billy Kelleher asked the Minister for Health the common and rarer side effects of the HPV vaccine; and if he will make a statement on the matter. [31694/11]

View answer

Written answers

The Irish Medicines Board (IMB) has responsibility for investigation of adverse reactions to medicines. Since the first authorisation of Gardasil, the IMB has continuously monitored its safety. This monitoring includes review of global safety data in addition to national experience with use of Gardasil.

Expected adverse effects from the vaccine, as described in the product information, include malaise, headache, dizziness, syncope (fainting), fatigue, skin and injection site reactions and gastrointestinal symptoms. Anaphylaxis is a well known but rare adverse event following immunisation which can occur following any immunisation. The adverse events reported to date to the IMB are within the acceptable limits as outlined in the Gardasil Summary of Product Characteristics and there are no safety concerns regarding the vaccine.

Billy Kelleher

Question:

147 Deputy Billy Kelleher asked the Minister for Health if the Health Service Executive paid for vaccination teams for the HPV vaccination programme; if not, the body which paid for same; and if he will make a statement on the matter. [31695/11]

View answer

The HPV immunisation programme is funded by the Health Service Executive.

Top
Share